Inventia Healthcare Limited: Chlorthalidone Tablets, Usp, 25 Mg, [100 Or 1000] Tablets Pr Bottle

Inventia Healthcare Limited is recalling Chlorthalidone Tablets, USP, 25 mg (in 100 or 1000-tablet bottles) distributed nationwide because the tablets do not dissolve properly in the body as specified. The affected products have NDC numbers 64980-599-01 and 64980-599-10 and were distributed by Risiong Pharma Holdings, Inc. to all U.S. states and territories.

Recalling firm

Inventia Healthcare Limited

Product

Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10

Reason

Failed Dissolution Specifications

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-06-05

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

U.S. Nationwide.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/c7c6e353-2824-45af-8d3f-ea2d36e15e9c